Acelyrin OverviewAcelyrin Research & Development
Research & Development expenses for SLRN.
Quarterly R&D Expenses
$42.14M
↓ 27.39% YoY
As of Mar 31, 2025
Annual R&D Expenses (TTM)
$222.16M
↓ 9.69% YoY
Trailing 12 months ending Mar 31, 2025
Acelyrin OverviewResearch & Development expenses for SLRN.
As of Mar 31, 2025
Trailing 12 months ending Mar 31, 2025